Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway

PC3 is a cell line characteristic of prostatic small cell carcinoma

(2011) Sheng Tai et al.   PROSTATE

Small Cell Carcinoma of the Prostate

(2009) Wenle Wang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer

(2009) Sak Kudahetti et al.   BJU INTERNATIONAL

Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-κB Synergy

(2009) Jiajia Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

SharedTP53gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate

(2009) Donna E. Hansel et al.   PROSTATE

Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer

(2009) Ganesh S. Palapattu et al.   PROSTATE

Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

(2008) Juan C. Acosta et al.   CELL

Clinical significance of p53 alterations in surgically treated prostate cancers

(2008) Thorsten Schlomm et al.   MODERN PATHOLOGY